This was confirmed in a xenograft mouse model, were a knockdown of Kv11.1 in CFPAC-1 cells showed reduced tumor growth and fewer metastatic nodules, compared to tumors in mice injected with control cells (Feng et al., 2014). This evidence concerns the gene KCNH2 and neoplasm.